Ali Afshar‐Oromieh

The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

Ali Afshar‐Oromieh, Eleni Avtzi, Frederik L. Giesel et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 974 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

Ali Afshar‐Oromieh, Christian M. Zechmann, A. Malcher et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 928 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with ¹⁷⁷Lu-Labeled PSMA-617

Clemens Kratochwil, Frederik L. Giesel, M. Stefanova et al. · Journal of Nuclear Medicine · 2016 · 621 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer

Martina Benešová, Martin Schäfer, Ulrike Bauder‐Wüst et al. · Journal of Nuclear Medicine · 2015 · 594 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients

Ali Afshar‐Oromieh, Tim Holland‐Letz, Frederik L. Giesel et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 515 citations · Full text

Medicine, Nuclear Medicine, Radiology +16